This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Controlled Clinical Trial of Desipramine

David J. Kupfer, MD; Ellen Frank, PhD
University of Pittsburgh School of Medicine Western Psychiatric Institute and Clinic 3811 O'Hara St Pittsburgh, PA 15213

Arch Gen Psychiatry. 1996;53(9):775-776.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THIS ISSUE of the ARCHIVES, Kocsis et al¹ present the results of their study on maintenance treatment for chronic depression. This study is an important sequel to their equally important earlier demonstration that patients with various forms of chronic depression do, indeed, respond to appropriate pharmacotherapy.² With the publication of these results, we now also have evidence that the vast majority of responders to pharmacotherapy remain well when they receive the maintenance pharmacotherapy. These results nicely parallel the earlier findings of Prien et al³ and Frank et al⁴ with respect to maintenance treatment of recurrent depression.

In their present report on maintenance outcomes, Kocsis et al¹ also discuss the "low" response rates to acute-phase pharmacotherapy in this population. There are several plausible explanations for the response rates obtained in the acute phase of their trial. First, Kocsis and colleagues chose the most stringent definition . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?